EUVIMEDEUVIMED entdecken
Open Access

La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity

Angelique E Boutzoukas, Daniel A Freedman, Christine Koterba, Garrett W Hunt, Kathy Mack, Jennifer Cass, Vedat O Yildiz, Emily de Los Reyes, Jaime Twanow, Melissa G Chung, Christopher P Ouellette iD

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciac403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Angelique E Boutzoukas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Duke University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: La Crosse virus, Encephalitis, California, Epilepsy. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Research Institute Nationwide Children’s Hospital, National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

La Crosse virus (LACV) is the most common neuroinvasive arboviral infection in children in the United States. However, data regarding predictors of disease severity and neurologic outcome are limited. Additionally, long-term neurologic and neurobehavioral outcomes remain relatively sparse.

Methods

This was a single-center, retrospective cohort study, followed by recruitment for a cross-sectional analysis of long-term neurobehavioral outcomes, among children aged 0–18 years with proven or probable LACV neuroinvasive disease (LACV-ND) between January 2009 and December 2018. Case ascertainment was assured by International Classification of Diseases, Ninth and Tenth Revision, Clinical Modification codes cross-referenced with laboratory results detecting LACV. Demographics, diagnostics, radiographs, and outcomes were evaluated. Recruitment of patients with prior diagnosis of LACV-ND occurred from January 2020 to March 2020, with assessment performed by validated pediatric questionnaires.

Results

One-hundred fifty-two children (83 males; median age, 8 years [interquartile range, 5–11.5 years]) were diagnosed with proven (n = 61 [47%]) and probable (n = 91 [60%]) LACV-ND. Sixty-five patients (43%) had severe disease. Altered mental status (AMS) (odds ratio [OR], 6.36 [95% confidence interval {CI}, 2.03–19.95]; P = .0002) and seizures at presentation (OR, 10.31 [95% CI, 3.45–30.86]; P = .0001) were independent predictors of severe disease. Epileptiform discharges on electroencephalogram (EEG) were independently associated with epilepsy diagnosis at follow-up (OR, 13.45 [95% CI, 1.4–128.77]; P = .024). Fifty-four patients were recruited for long-term neurobehavioral follow-up, with frequent abnormal assessments identified (19%–54%) irrespective of disease severity.

Conclusions

Severe disease was observed frequently among children with LACV-ND. Seizures and AMS at presentation were independent predictors of severe disease. EEG may help determine long-term epilepsy risk. Long-term neurobehavioral issues are frequent and likely underrecognized among children with LACV-ND.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

La Crosse virusEncephalitis, CaliforniaEpilepsyMaleHumansChildUnited StatesCross-Sectional StudiesRetrospective StudiesPatient AcuitySeizures

Stichwörter der Autor:innen

La Crosse virusencephalitispediatric

Autor:innen und Institutionen

  • Department of Pediatrics, Duke University, Durham, North Carolina, USA.
  • Duke Clinical Research Institute, Durham, North Carolina, USA.
  • Department of Neurology, Dell Medical School, Austin, Texas, USA.
  • Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio, USA.
  • Division of Psychology and Neuropsychology, Nationwide Children's Hospital, Columbus, OH, USA.
  • Division of Infectious Diseases, Nationwide Children's Hospital, Columbus, OH, USA.

ORCID-Profile: Christopher P Ouellette

Förderung

  • NICHD NIH HHS
  • Research Institute Nationwide Children’s Hospital
  • National Institute of Child Health and Human Development
  • National Institutes of Health

Zitieren

APA

Boutzoukas, A. E., Freedman, D. A., Koterba, C., Hunt, G. W., Mack, K., Cass, J., Yildiz, V. O., de Los Reyes, E., Twanow, J., Chung, M. G., & Ouellette, C. P. (2023). La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac403

Vancouver

Boutzoukas AE, Freedman DA, Koterba C, Hunt GW, Mack K, Cass J, et al. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac403

BibTeX
@article{Boutzoukas2023,
  author = {Boutzoukas, Angelique E and Freedman, Daniel A and Koterba, Christine and Hunt, Garrett W and Mack, Kathy and Cass, Jennifer and Yildiz, Vedat O and de Los Reyes, Emily and Twanow, Jaime and Chung, Melissa G and Ouellette, Christopher P},
  title = {La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciac403}
}
Kostenlos starten →